5 news items
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance
SCNI
24 May 24
This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words such as "expect
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
SCNI
15 May 24
This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
SCNI
6 May 24
This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995. Words
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services
SCNI
8 Apr 24
This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act
Scinai leadership to attend BIO-Europe Spring 2024
SCNI
12 Mar 24
of the Private Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "plan," "continue," "may
- Prev
- 1
- Next